Literature DB >> 22310949

Diabetes: glycemic control and outcomes in people with diabetes and CKD.

Sophia Zoungas1, John Chalmers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22310949     DOI： 10.1038/nrneph.2012.18

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

2.  Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds.

Authors:  S Zoungas; J Chalmers; T Ninomiya; Q Li; M E Cooper; S Colagiuri; G Fulcher; B E de Galan; S Harrap; P Hamet; S Heller; S MacMahon; M Marre; N Poulter; F Travert; A Patel; B Neal; M Woodward
Journal:  Diabetologia       Date:  2011-12-21       Impact factor: 10.122

3.  Severe hypoglycemia and risks of vascular events and death.

Authors:  Sophia Zoungas; Anushka Patel; John Chalmers; Bastiaan E de Galan; Qiang Li; Laurent Billot; Mark Woodward; Toshiharu Ninomiya; Bruce Neal; Stephen MacMahon; Diederick E Grobbee; Andre Pascal Kengne; Michel Marre; Simon Heller
Journal:  N Engl J Med       Date:  2010-10-07       Impact factor: 91.245

4.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

5.  Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.

Authors:  Craig J Currie; John R Peters; Aodán Tynan; Marc Evans; Robert J Heine; Oswaldo L Bracco; Tony Zagar; Chris D Poole
Journal:  Lancet       Date:  2010-01-26       Impact factor: 79.321

6.  Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study.

Authors:  Sabin Shurraw; Brenda Hemmelgarn; Meng Lin; Sumit R Majumdar; Scott Klarenbach; Braden Manns; Aminu Bello; Matthew James; Tanvir Chowdhury Turin; Marcello Tonelli
Journal:  Arch Intern Med       Date:  2011-11-28

7.  Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.

Authors:  Kay-Tee Khaw; Nicholas Wareham; Sheila Bingham; Robert Luben; Ailsa Welch; Nicholas Day
Journal:  Ann Intern Med       Date:  2004-09-21       Impact factor: 25.391

8.  Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial.

Authors:  Matthew C Riddle; Walter T Ambrosius; David J Brillon; John B Buse; Robert P Byington; Robert M Cohen; David C Goff; Saul Malozowski; Karen L Margolis; Jeffrey L Probstfield; Adrian Schnall; Elizabeth R Seaquist
Journal:  Diabetes Care       Date:  2010-05       Impact factor: 19.112

9.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

10.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245
  10 in total
  2 in total

1.  How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study.

Authors:  Alfred Penfornis; Jean Frédéric Blicklé; Béatrice Fiquet; Stéphane Quéré; Sylvie Dejager
Journal:  Vasc Health Risk Manag       Date:  2014-06-13

2.  Hydrogen sulfide ameliorates chronic renal failure in rats by inhibiting apoptosis and inflammation through ROS/MAPK and NF-κB signaling pathways.

Authors:  Dongdong Wu; Ning Luo; Lianqu Wang; Zhijun Zhao; Hongmin Bu; Guoliang Xu; Yongjun Yan; Xinping Che; Zhiling Jiao; Tengfu Zhao; Jingtao Chen; Ailing Ji; Yanzhang Li; Garrick D Lee
Journal:  Sci Rep       Date:  2017-03-28       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.